Derek Hicks
Vermogen: 842 483 $ op 31-05-2026
Vermogen: 842 483 $ op 31-05-2026
Derek Hicks currently works at Rezo Therapeutics, Inc., as Chief Executive Officer from 2025.
Mr. Hicks also formerly worked at Spark Therapeutics, Inc., as Head-Business Development from 2020 to 2021 and Intellia Therapeutics, Inc., as Chief Business Officer & Executive Vice President.
Mr. Hicks received his undergraduate degree and graduate degree from the University of Connecticut and Masters Business Admin degree from Kelley School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-01-2025 | 59.878 ( 0,04% ) | 842 483 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Algemeen Directeur | 12-08-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2021 |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau